One example being a recent study by Zunke et al. on the “Reversible Conformational Conversion of α-Synuclein Toxic Assemblies by Glucosylceramide”, where the reduction of glycosphingolipid diminished PD pathology in patient-derived neurons [20]. Here, SNCA is linked to Parkinson disease.